Experience

Sling Therapeutics

• United States
• Biotechnology
• 1 - 100 Employee

• Chief Medical Officer

  • Jan 2023 - 1 year



Horizon

• Ireland
• Biotechnology Research
• 700 & Above Employee

• Executive Vice President, Medical Affairs and Outcomes Research

  • Oct 2019 - Jan 2023

  • Led all aspects of Global Medical Affairs function and HEOR reporting to the CEO • Built team from 10 - 150 in support of rare, immune-modulating, rheumatology, and ophthalmology portfolios • Established international medical organization from inception while driving significant growth of US business through field execution, evidence generation, KOL development, publication strategy, and conference presence • Managed and directed $100M operational budget • Partnered at executive… Show more • Led all aspects of Global Medical Affairs function and HEOR reporting to the CEO • Built team from 10 - 150 in support of rare, immune-modulating, rheumatology, and ophthalmology portfolios • Established international medical organization from inception while driving significant growth of US business through field execution, evidence generation, KOL development, publication strategy, and conference presence • Managed and directed $100M operational budget • Partnered at executive level on development strategy, BLA prep, and advisory committee execution • Active member of multiple senior level teams evaluating business development opportunities, corporate strategy, and pipeline development • Quarterly attendance and presentation to Board of Directors

• Senior Vice President, Head of Medical Affairs & Outcomes Research

  • May 2012 - Oct 2019

  Deerfield, IL



Astellas Pharma US

• United States
• Pharmaceutical Manufacturing
• 700 & Above Employee

• Executive Medical Director

  • Dec 2011 - May 2012

  Deerfield, Illinois • Led US Medical Affairs across diverse portfolio partnering with R&D and Commercial on strategic direction • Directed publication strategy, Phase IIB/IV execution, KOL development, and advocacy



Abbott

• United States
• Hospitals and Health Care
• 700 & Above Employee

• Global Project Head/Project Director

  • 2003 - Dec 2011

  • Led Global Medical Affairs function for HUMIRA with a team of 75 • Fully responsible and accountable for budget, strategy, and direction of medical group in support of multiple indications and launches across therapeutic areas and geographies • Portfolio of activity included evidence generation, publication strategy and execution, KOL development, medical education, IIT and IIIB/4 trials, and advocacy



Searle

• Pharmaceutical Manufacturing
• 200 - 300 Employee

• Medical Director

  • 1999 - 2003

  • Participated as key member of clinical development team on groundbreaking COX 2 inhibitor CELEBREX • Led clinical development of follow-on COX 2 VALDECOXIB. Activities included multiple NDAs, advisory committees, and launches



Rush Presbyterian Medical Center - Chicago

• Attending Physician

  • 1992 - 1997

  Clinical Gastroenterology